{
    "eid": "2-s2.0-85134551371",
    "title": "Synchrotron Fourier Transform Infrared Microscopy Spectra in Cellular Effects of Janus Kinase Inhibitors on Myelofibrosis Cancer Cells",
    "cover-date": "2022-07-05",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Chemistry (all)",
            "@code": "1600",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Chemical Engineering (all)",
            "@code": "1500",
            "@abbrev": "CENG"
        }
    ],
    "keywords": [],
    "authors": [
        "Jeeraprapa Siriwaseree",
        "Kamonpan Sanachai",
        "Thitinan Aiebchun",
        "Lueacha Tabtimmai",
        "Buabarn Kuaprasert",
        "Kiattawee Choowongkomon"
    ],
    "citedby-count": 1,
    "ref-count": 36,
    "ref-list": [
        "The JAK-STAT Pathway at Twenty",
        "JAKs and STATs in Immunity, Immunodeficiency, and Cancer",
        "Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib",
        "JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects (vol 77, pg 521, 2017)",
        "Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling",
        "The Use of Structural Biology in Janus Kinase Targeted Drug Discovery",
        "JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders",
        "Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: Therapeutic implications for the treatment of myeloproliferative neoplasms",
        "Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6",
        "Ouabain-induced modifications of prostate cancer cell lipidome investigated with mass spectrometry and FTIR spectroscopy",
        "Basis of a FTIR spectroscopy methodology for automated evaluation of Akt kinase inhibitor on leukemic cell lines used as model",
        "Probing the action of a novel anti-leukaemic drug therapy at the single cell level using modern vibrational spectroscopy techniques",
        "Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin",
        "INCB16562, a JAK1/2 Selective Inhibitor, Is Efficacious against Multiple Myeloma Cells and Reverses the Protective Effects of Cytokine and Stromal Cell Support",
        "Computer aided designing of novel pyrrolopyridine derivatives as JAK1 inhibitors",
        "Insights into the Binding Recognition and Susceptibility of Tofacitinib toward Janus Kinases",
        "FTIR microspectroscopy defines early drug resistant human hepatocellular carcinoma (HepG2) cells",
        "Fourier Transform Infrared (FTIR) Spectroscopy of Biological Tissues",
        "Infrared spectroscopy and microscopy in cancer research and diagnosis",
        "A Preliminary Study of FTIR Spectroscopy as a Potential Non-Invasive Screening Tool for Pediatric Precursor B Lymphoblastic Leukemia",
        "Accumulation of JAK activation loop phosphorylation is linked to type i JAK inhibitor withdrawal syndrome in myelofibrosis",
        "A Road Map for Those Who Don't Know JAK-STAT",
        "Jakinibs: A new class of kinase inhibitors in cancer and autoimmune disease",
        "JAK inhibition as a therapeutic strategy for immune and inflammatory diseases",
        "Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates",
        "Fourier Transform Infrared (FTIR) Spectroscop\\y",
        "Does Fourier-transform infrared spectroscopy provide useful information on protein structures?",
        "Cytokine Signaling in Tumor Progression",
        "JAK-STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma",
        "Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC",
        "Ruxolitinib Regulates the Autophagy Machinery in Multiple Myeloma Cells",
        "Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer",
        "Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment",
        "The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis",
        "Dissecting specificity in the Janus kinases: The structures of JAK-specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine kinase domains"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60103462",
            "affilname": "King Mongkut's University of Technology North Bangkok",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103462",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60021944",
            "affilname": "Kasetsart University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021944",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Ratchasrima",
            "@id": "126156155",
            "affilname": "Synchrotron Light Research Institute (Public Organization)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126156155",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Research Council of Thailand",
        "Kasetsart University Research and Development Institutes",
        "Synchrotron Light Research Institute"
    ]
}